Quinine dihydrochloride is a crucial treatment for severe malaria, particularly when complicated by conditions like cerebral malaria or when patients are unable to take oral medication. Its key advantage is that it can be administered intravenously for rapid action. It is also used to treat babesiosis, a tick-borne parasitic infection. Like other forms of quinine, it targets and damages malaria parasites within red blood cells. However, due to its potency and potential for serious side effects, administration requires careful medical supervision in a healthcare setting with appropriate monitoring.
Quinine dihydrochloride effectively treats severe malaria by eliminating parasites, but it carries a risk of side effects. These include cinchonism (tinnitus, headache, nausea, vision problems), cardiovascular issues, low blood sugar, blood disorders, allergic reactions, and potential injection site reactions. Due to these risks, it requires administration in a healthcare setting with careful medical supervision and monitoring.